DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Wedbush Maintains Outperform on Voyager Therapeutics, Lowers Price Target to $27

Wedbush maintains Voyager Therapeutics (NASDAQ:VYGR) with a Outperform and lowers the price target from $34 to $27.

Benzinga · 03/04/2020 12:56

Wedbush maintains Voyager Therapeutics (NASDAQ:VYGR) with a Outperform and lowers the price target from $34 to $27.